Delivery Order SPE2D021DA002-SPE2D325F416G
- Not listed
- The Defense Logistics Agency (DLA), acting under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 2, 2025, has a ceiling value of $1,916.75 and is scheduled for completion by October 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance by the vendor from its location in Park Ridge, Illinois. DMS Pharmaceutical...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector units (quantity 2). This firm fixed-price delivery order, valued at $1,742.50, was issued on October 2, 2025, with an ultimate completion date of October 3, 2025, and does not include a set-aside designation. The order will be fulfilled from the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc....
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $2,644.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the delivery of epinephrine auto-injectors with a period of performance through May 3, 2024. This delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for Epinephrine 0.3 mg auto-injector units (2-pack configuration) with a ceiling value of $1,394.00. The award, issued on July 23, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. This delivery order was issued without set-aside designation and is being fulfilled at the contractor's facility in...
- The U.S. Defense Logistics Agency Medical Supply Chain issued a firm fixed-price delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is expected to be completed by September 5, 2025, and represents performance at the vendor's Park...
- The Defense Logistics Agency, through its Medical Supply Chain function, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Epinephrine 0.3 mg auto-injector two-packs. The contract, valued at $1,742.50 with an ultimate completion date of August 25, 2025, was awarded on August 20, 2025, on a firm fixed-price basis with no set-aside designation. The vendor will perform deliveries from its Park Ridge, Illinois facility. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,742.50 by the Defense Logistics Agency's Medical Supply Chain division on September 2, 2025. The contract calls for the delivery of Epinephrine 0.3 mg auto-injector units (2-pack) to support federal healthcare operations. The delivery order carries an ultimate completion date of September 5, 2025, and represents...
- The Defense Logistics Agency (DLA) issued a delivery order valued at $1,219.75 to DMS Pharmaceutical Group Inc. on July 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (two-pack units). This firm fixed-price delivery order, which must be completed by July 25, 2025, represents a routine pharmaceutical supply fulfillment under the agency's medical logistics operations. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of epinephrine injections. This $1,866.40 firm fixed-price delivery order was issued on October 2, 2025, with an ultimate completion date of October 14, 2025. The award carries no set-aside designation and will be fulfilled from the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. The award, issued on September 5, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Park Ridge location. The...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F416GDelivery Order
The Defense Logistics Agency (DLA), operating under the Medical Supply Chain function, awarded a delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-inject 2-packs. The delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, is structured as a firm fixed-price contract with no set-aside designation. The product will be delivered to Park Ridge, Illinois, the location of the prime contractor's operations. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at approximately $500 million and valid through November 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, providing comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities. The company has maintained an established presence in federal contracting since its 2001 SAM.gov registration and leverages its small business status to compete effectively in federal procurement markets for medical supply and pharmaceutical distribution needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/16/25 |